Moderna Therapeutics and the search for a COVID-19 vaccine

May 9, 2020
In this special weekend edition of Good Day BIO, we’re introducing Biotechnology: Beyond Imagination, a new series highlighting the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Featuring videos and blog posts…
BIO

In this special weekend edition of Good Day BIO, we’re introducing Biotechnology: Beyond Imagination, a new series highlighting the technology and scientific advancements of BIO Digital participating companies and BIO member companies.

Featuring videos and blog posts that will enhance your understanding of technologies being developed in our industry, this series will demonstrate how cutting-edge advancements hold promise for our future and truly go beyond imagination.

Moderna Therapeutics and the search for a COVID-19 vaccine

Moderna Therapeutics is one of many biotechnology companies searching for a vaccine for the novel coronavirus. Who is Moderna, and what makes their approach different?

The Massachusetts-based Moderna Therapeutics worked with the National Institutes of Health (NIH) and brainstormed and developed a potential COVID-19 vaccine in just 42 days.

And already, it's been approved by the Food and Drug Administration (FDA) for Phase 2 clinical trials.

And they did this without ever having access to the virus itself. “Working with the NIH, we worked to decide and design the vaccine literally on our computers,” said Moderna CEO Stéphane Bancel. “We never had access to the virus, but we had access to something we believe is more important than the physical virus, which is the genetic makeup of the virus: its sequence.”

What makes their approach different? Messenger RNA. 

Watch to learn more:

 
Twitter
 
LinkedIn
 
Facebook
 
Moderna's COVID-19 Vaccine

And while the vaccine is not approved yet, Moderna’s already ramping up manufacturing capabilities to allow for rapid production. 

Read more about Moderna’s vaccine candidate and the race to end COVID-19.

Listen to Moderna CEO Stéphane Bancel on the I AM BIO Podcast.

Want to learn more about why nothing—not even a pandemic—stops innovation? Register for BIO Digital from June 8-12, 2020.

 

 
Twitter
 
LinkedIn
 
Facebook
 
BIO Digital 2020 - Click to Register